Event rates, hospital utilization, and costs associated with major complications of diabetes: a multicountry comparative analysis. PLoS Medicine. 2010;7:e1000236.
Event rates in trials of patients with type 2 diabetes. Journal of the American Medical Association (JAMA). 2010;303:732; author reply 733..
Management of chronic kidney disease in Australian general practice (the AusHEART Study). 46th Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology. 2010.
Oral disease and subsequent cardiovascular disease in people with type 2 diabetes: a prospective cohort study based on the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified-Release Controlled Evaluation (ADVANCE) trial. Diabetologia. 2010;53:2320-7.
Protection against cardiovascular and renal disease in type 2 diabetes: ADVANCEs in the control of blood pressure using Preterax and Diamicron MR. Issue IV. France: Wolters Kluwer Health France; 2010.